Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2024 年第 1 季持倉
持倉截至 2024/3/31，2024/5/15 申報。只含多頭部位，變化是跟 2023 年第 4 季比股數。
- 持股檔數
- 65
- 較 2023 年第 4 季 +8
- 總值
- $34.8 億
- 較 2023 年第 4 季 +$6.24 億 (+21.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,479,853 | $1.71 億 | 4.9% | −583,823−14.4% | 減碼 | 歷史 |
| AMGNAmgen Inc | Stock | 550,000 | $1.56 億 | 4.5% | +550,000 | 新進 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 2,323,456 | $1.54 億 | 4.4% | 00.0% | 不變 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 4,783,679 | $1.30 億 | 3.7% | −566,321−10.6% | 減碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 4,555,383 | $1.29 億 | 3.7% | +2,555,383+127.8% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 832,310 | $1.24 億 | 3.6% | +832,310 | 新進 | 歷史 |
| GHGuardant Health, Inc. | COM | 6,000,000 | $1.24 億 | 3.6% | +1,000,000+20.0% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 300,000 | $1.18 億 | 3.4% | 00.0% | 不變 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 4,210,784 | $1.16 億 | 3.3% | +1,960,784+87.1% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 12,721,460 | $1.16 億 | 3.3% | +3,490,691+37.8% | 加碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 9,141,660 | $1.13 億 | 3.3% | +2,048,446+28.9% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 1,304,721 | $1.04 億 | 3.0% | +304,721+30.5% | 加碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 1,500,000 | $1.04 億 | 3.0% | −500,000−25.0% | 減碼 | 歷史 |
| GERNGeron Corp | COM | 30,505,929 | $1.01 億 | 2.9% | +922,480+3.1% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 15,272,172 | $9,744 萬 | 2.8% | +3,402,875+28.7% | 加碼 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 3,034,453 | $9,668 萬 | 2.8% | +750,081+32.8% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 3,500,000 | $9,475 萬 | 2.7% | −500,000−12.5% | 減碼 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 3,490,506 | $8,691 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 5,750,000 | $8,568 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | Stock | 6,666,667 | $6,267 萬 | 1.8% | +6,666,667 | 新進 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 4,297,438 | $6,145 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 3,456,053 | $6,052 萬 | 1.7% | −175,675−4.8% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 1,373,475 | $5,954 萬 | 1.7% | +124,407+10.0% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,000,000 | $5,878 萬 | 1.7% | +1,000,000 | 新進 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 822,001 | $5,682 萬 | 1.6% | +222,001+37.0% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 7,370,000 | $5,682 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 3,187,415 | $5,129 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 1,262,246 | $5,074 萬 | 1.5% | +1,262,246 | 新進 | 歷史 |
| IVVDInvivyd, Inc. | COM | 10,953,937 | $4,864 萬 | 1.4% | +10,953,937 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,213,420 | $4,603 萬 | 1.3% | −739,340−37.9% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 2,997,830 | $4,407 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| HLVXHilleVax, Inc. | COM | 2,572,460 | $4,278 萬 | 1.2% | −327,540−11.3% | 減碼 | 歷史 |
| EDITEditas Medicine, Inc. | COM | 5,527,290 | $4,101 萬 | 1.2% | +54,204+1.0% | 加碼 | 歷史 |
| FATEFate Therapeutics Inc | COM | 5,572,607 | $4,090 萬 | 1.2% | +5,572,607 | 新進 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 6,100,000 | $4,002 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 2,250,000 | $3,814 萬 | 1.1% | +2,250,000 | 新進 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 1,595,400 | $3,653 萬 | 1.1% | −220,454−12.1% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,225,419 | $3,651 萬 | 1.0% | +1,294,525+67.0% | 加碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,643,881 | $3,551 萬 | 1.0% | −307,699−15.8% | 減碼 | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 7,000,000 | $2,625 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| Cybin Ord23256X100 | COM | 58,139,535 | $2,404 萬 | 0.7% | +58,139,535 | 新進 | – |
| ALECAlector, Inc. | COM | 3,769,386 | $2,269 萬 | 0.7% | +3,769,386 | 新進 | 歷史 |
| NUVLNuvalent, Inc. | COM | 274,512 | $2,061 萬 | 0.6% | −175,488−39.0% | 減碼 | 歷史 |
| AGENAgenus Inc | COM NEW | 31,697,539 | $1,838 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 4,184,100 | $1,782 萬 | 0.5% | +4,184,100 | 新進 | 歷史 |
| NKTRNektar Therapeutics | COM | 18,400,000 | $1,719 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| IMVTImmunovant, Inc. | COM | 493,352 | $1,594 萬 | 0.5% | −506,648−50.7% | 減碼 | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 1,000,000 | $1,375 萬 | 0.4% | +1,000,000 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 2,684,344 | $1,264 萬 | 0.4% | −308,387−10.3% | 減碼 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 680,000 | $1,208 萬 | 0.3% | −331,829−32.8% | 減碼 | 歷史 |
| ANABAnaptysbio, Inc | COM | 529,452 | $1,192 萬 | 0.3% | −1,507,538−74.0% | 減碼 | 歷史 |
| RGLSRegulus Therapeutics Inc. | COM | 3,266,566 | $940.8 萬 | 0.3% | +3,266,566 | 新進 | 歷史 |
| ANROAlto Neuroscience, Inc. | COM SHS | 600,000 | $921.0 萬 | 0.3% | +600,000 | 新進 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 167,784 | $783.4 萬 | 0.2% | +167,784 | 新進 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,523,000 | $648.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ALLKAllakos Inc. | COM | 5,000,000 | $630.0 萬 | 0.2% | +2,489,264+99.1% | 加碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM | 6,102,770 | $598.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 1,240,034 | $576.6 萬 | 0.2% | −804,473−39.3% | 減碼 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,594,931 | $543.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MGXMetagenomi Therapeutics, Inc. | COM | 466,232 | $491.9 萬 | 0.1% | +466,232 | 新進 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 828,485 | $443.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 579,674 | $259.7 萬 | 0.1% | +579,674 | 新進 | 歷史 |
| PRMEPrime Medicine, Inc. | COM | 303,716 | $212.6 萬 | 0.1% | +303,716 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 316,000 | $212.4 萬 | 0.1% | +316,000 | 新進 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 40,137 | $172.0 萬 | <0.1% | −259,863−86.6% | 減碼 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| ITCIIntra-Cellular Therapies, Inc. | COM | $1,214 萬 | – |
2023 年第 4 季之後清倉（11 檔）
2023 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 4 季股數 | 2023 年第 4 季市值 | 2023 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| AMAMAmbrx Biopharma, Inc. | COM | 3,710,412 | $5,284 萬 | 1.9% | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 500,000 | $4,822 萬 | 1.7% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,793,966 | $4,458 萬 | 1.6% | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 725,145 | $4,025 萬 | 1.4% | 歷史 |
| ORTXOrchard Therapeutics plc | SPON ADS NEW | 2,041,670 | $3,359 萬 | 1.2% | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 2,537,176 | $2,776 萬 | 1.0% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 288,949 | $2,412 萬 | 0.8% | 歷史 |
| AGIOAgios Pharmaceuticals, Inc. | COM | 1,062,881 | $2,367 萬 | 0.8% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 275,201 | $631.0 萬 | 0.2% | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 48,280 | $593.8 萬 | 0.2% | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 499,400 | $289.7 萬 | 0.1% | 歷史 |